Pharmafile Logo

Glaucoma in perspective

- PMLiVE

To support patient-centricity in clinical trials, look to rare disease communities

How patients are seeking new treatment options that will advance the care of their communities

- PMLiVE

Ipsen’s Bylvay approved by FDA for severe itching due to Alagille syndrome

As many as 88% of patients living with the condition experience severe pruritus

- PMLiVE

Merck’s efinopegdutide shows promise in nonalcoholic fatty liver disease

The candidate was recently granted FDA fast track designation for a severe form of NAFLD

- PMLiVE

Almirall survey reveals limited knowledge of most common precancerous skin condition

Up to 80% of squamous cell carcinomas develop from actinic keratosis lesions

- PMLiVE

Havas reveals new brand architecture and visual identity

The agency will bring its branded networks and operating companies under one shared identity

- PMLiVE

Inizio appoints Shauna Aherne as president of medical excellence

Aherne has two decades of leadership experience in the pharmaceutical industry

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links